Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 52-Week High - Here's What Happened

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report)'s share price reached a new 52-week high during trading on Thursday . The stock traded as high as $11.28 and last traded at $10.94, with a volume of 27479 shares traded. The stock had previously closed at $10.76.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Fresenius SE & Co. KGaA in a report on Monday, February 3rd.

Fresenius SE & Co. KGaA Stock Up 0.6 %

The firm has a market cap of $22.39 billion, a price-to-earnings ratio of 47.72 and a beta of 0.86. The firm has a 50-day moving average of $10.30 and a two-hundred day moving average of $9.50. The company has a current ratio of 1.36, a quick ratio of 1.05 and a debt-to-equity ratio of 0.57.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.18 earnings per share (EPS) for the quarter. The company had revenue of $6.01 billion during the quarter. As a group, sell-side analysts predict that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.